These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9684781)

  • 21. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2N von Willebrand disease.
    Mazurier C; Hilbert L
    Curr Hematol Rep; 2005 Sep; 4(5):350-8. PubMed ID: 16131435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.
    Nitu-Whalley IC; Riddell A; Lee CA; Pasi KJ; Owens D; Enayat MS; Perkins SJ; Jenkins PV
    Thromb Haemost; 2000 Dec; 84(6):998-1004. PubMed ID: 11154147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA.
    Eikenboom JC; Ploos van Amstel HK; Reitsma PH; Briët E
    Thromb Haemost; 1992 Oct; 68(4):448-54. PubMed ID: 1448779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UHG-based mutation screening in type 2B von Willebrand's disease: detection of a candidate mutation Ser547Phe.
    Wood N; Standen GR; Bowen DJ; Cumming A; Lush C; Lee R; Bidwell J
    Thromb Haemost; 1996 Feb; 75(2):363-7. PubMed ID: 8815591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 2N von Willebrand disease: Characterization and diagnostic difficulties.
    Casonato A; Galletta E; Sarolo L; Daidone V
    Haemophilia; 2018 Jan; 24(1):134-140. PubMed ID: 29115006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on genetic mutations of the vWF in type 2A von Willebrand disease].
    Wang Y; Zhang J; Zhang W; Cheng D; Wan H; Ruan C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):229-32. PubMed ID: 10932002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular study of type 2 von Willebrand disease].
    Habart D; Smejkal P; Matýsková M; Turek P; Hrachovinová I; Vorlová Z
    Cas Lek Cesk; 2003; 142(6):373-6. PubMed ID: 12924038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
    Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
    Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular study of VWF gene from Mexican Mestizo patients with von Willebrand disease, and the finding of three new mutations.
    Melo-Nava BM; Benítez H; Palacios JJ; Nieva B; Arenas D; Jaloma-Cruz AR; Navarrete C; Salamanca F; Peñaloza R
    Blood Cells Mol Dis; 2007; 39(3):361-5. PubMed ID: 17681836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease.
    Kashiwagi T; Matsushita T; Ito Y; Hirashima K; Sanda N; Fujimori Y; Yamada T; Okumura K; Takagi A; Murate T; Katsumi A; Takamatsu J; Yamamoto K; Naoe T; Kojima T
    Haemophilia; 2008 May; 14(3):556-63. PubMed ID: 18397285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.
    Castaman G; Giacomelli SH; Jacobi P; Obser T; Budde U; Rodeghiero F; Haberichter SL; Schneppenheim R
    J Thromb Haemost; 2010 Sep; 8(9):2011-6. PubMed ID: 20586924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
    Keeney S; Bowen D; Cumming A; Enayat S; Goodeve A; Hill M;
    Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
    Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
    Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor level.
    Mohlke KL; Purkayastha AA; Westrick RJ; Ginsburg D
    Genomics; 1998 Nov; 54(1):19-30. PubMed ID: 9806826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of inherited von Willebrand disease in 2007.
    Federici AB; Mannucci PM
    Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
    Rick ME; Krizek DM
    Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.